V Grasso, G Gutierrez, N Alzbeidi… - Progress in Neuro …, 2024 - Elsevier
Background Unipolar treatment-resistant depression (MDD-TRD) is associated with neurocognitive impairment. Ketamine, an emerging treatment for MDD-TRD, may have …
E Ahern, J White, E Slattery - Neuropsychology Review, 2024 - Springer
Major depressive disorder (MDD) is associated with significant cognitive deficits during the acute and remitted stages. The aim of this systematic review and meta-analysis was to …
Background Cognitive deficits are often comorbid with mood disorders and can cause significant functional impairment even after resolution of the primary mood symptoms. We do …
Abstract Background Major Depressive Disorder (MDD) is a heterogenous brain disorder, with potentially multiple psychosocial and biological disease mechanisms. This is also a …
E Małujło-Balcerska, T Pietras - Journal of psychiatric research, 2024 - Elsevier
Background Depressive disorder is a complex mental health condition in which the etiopathogenesis involves several factors. Suitable biomarkers for the development of …
GM Vulpius, K Köhler-Forsberg… - International Journal …, 2023 - academic.oup.com
Background A prominent finding in major depressive disorder (MDD) is distorted stress hormone dynamics, which is regulated by serotonergic brain signaling. An interesting …
The involvement of serotonin in emotion and psychopathology has been extensively examined. Studies using acute tryptophan depletion (ATD) have found limited effects on …
HZ Ab Latiff, S Ariaratnam, N Shuib, MR Isa - Healthcare, 2023 - mdpi.com
Background: Major Depressive Disorder (MDD) is a significant and common mental health problem occurring worldwide. Cognitive decline is frequently observed during acute and …
Background Methylation of serotonin-related genes has been proposed as a plausible gene- by-environment link which may mediate environmental stress, depressive and anxiety …